DEEP PHENOTYPING OF CHILDREN WITH ASD, MACROCEPHALY, AND PHOSPHATIDYLINOSITOL 3-KINASE/PROTEIN KINASE B/MAMMALIAN TARGET OF RAPAMYCIN (PI3K/AKT/MTOR) PATHWAY MUTATIONS: PRELIMINARY FINDINGS

被引：0
|
作者：
Besterman, Aaron D. [1 ]
Nguyen, Dzung Maria [1 ]
Sadik, Joshua [1 ]
Bhatt, Rujuta [1 ]
Hellemann, Gerhard [1 ]
McCracken, James T. [1 ]
Martinez, Julian A. [1 ]
机构：
[1] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 2018年 / 57卷 / 10期
关键词：
D O I：
10.1016/j.jaac.2018.09.303
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
5.8
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [1] Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
    Wanigasooriya, Kasun
    Tyler, Robert
    Barros-Silva, Joao D.
    Sinha, Yashashwi
    Ismail, Tariq
    Beggs, Andrew D.
    CANCERS, 2020, 12 (05)
  • [2] Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management
    Khan, Khurum H.
    Wong, Mabel
    Rihawi, Karim
    Bodla, Shankar
    Morganstein, Daniel
    Banerji, Udai
    Molife, Lulama R.
    ONCOLOGIST, 2016, 21 (07): : 855 - 860
  • [3] Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: An emerging treatment strategy for squamous cell lung carcinoma
    Beck, Joseph Thaddeus
    Ismail, Amen
    Tolomeo, Christina
    CANCER TREATMENT REVIEWS, 2014, 40 (08) : 980 - 989
  • [4] Tubastatin A suppresses the proliferation of fibroblasts in epidural fibrosis through phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway
    Liu, Yang
    Wang, Ruihong
    Han, Huimin
    Li, Li
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2022, 74 (03) : 426 - 434
  • [5] Mammalian Target of Rapamycin, Akt, and Phosphatidylinositol 3-Kinase Signaling
    Pal, Sumanta K.
    Reckamp, Karen L.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S487 - S489
  • [6] Review: Schistosoma mansoni phosphatidylinositol 3 kinase (PI3K)/Akt/mechanistic target of rapamycin (mTOR) signaling pathway
    Abou-El-Naga, Iman F.
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 2021, 256
  • [7] Vitexin Inhibits the Proliferation and Promotes the Apoptosis of Gastric Cancer Cells via Phosphatidylinositol-3-Kinase (PI3K)/Protein Kinase B (Akt)/The Mammalian Target of Rapamycin (mTOR) Signaling Pathway
    Lu, M. M. Jiashu
    Yu, M. M. Lei
    Ma, M. M. Ying
    Li, M. M. Jie
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2020, 10 (12) : 1843 - 1850
  • [8] Everolimus Reverses Palbociclib Resistance in ER plus Human Breast Cancer Cells by Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway
    Chen, Lin
    Yang, Guangsheng
    Dong, Hongming
    MEDICAL SCIENCE MONITOR, 2019, 25 : 77 - 86
  • [9] Ursolic Acid Attenuates High Glucose-Mediated Mesangial Cell Injury by Inhibiting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Signaling Pathway
    Wang, Er-Min
    Fan, Qiu-Ling
    Yue, Yuan
    Xu, Li
    MEDICAL SCIENCE MONITOR, 2018, 24 : 846 - 854
  • [10] Phosphatidylinositol 3-kinase (PI3K) pathway - A therapeutic target for human glioblastoma
    Koul, Dimpy
    Shen, Ruijun
    Edge, Jennifer
    Liu, T. J.
    Powis, Garth
    Lynn Kirkpatrick, D.
    Alfred Yung, W. K.
    NEURO-ONCOLOGY, 2006, 8 (04) : 414 - 414
12345